Enveric Biosciences, Inc. · NASDAQ:ENVB
Coveney Kevin Michael received 133,333 Enveric Biosciences, Inc. shares as an award (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Coveney Kevin Michael (Chief Financial Officer) received 133,333 Enveric Biosciences, Inc. shares as an award, leaving 180,746 shares. Filed Jun 3, 2026 (Form 4).
- Awarded
- 133,333 shares
- Holding after
- 180,746 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Award | 133,333 | 180,746 | Direct |
Source
Related
- Enveric Biosciences, Inc.
- Coveney Kevin Michael
- Enveric Biosciences, Inc. shareholders
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026
- Form 4 · Pasqualone Frank · Jun 3, 2026